Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer
Pharma Tech
Germany approves healthcare costs overhaul despite significant pharma opposition
There are a range of cost-containment measures across the bill that will create a significant healthcare system shakeup.
Read Full Article
PharmaShots
Michael Wysocki on Precision Molecular Imaging & PSMA PET Innovation: Blue Earth Diagnostics’ Vision for Personalized Prostate Cancer Care
Shots: Saurabh: Molecular imaging is rapidly transforming oncology diagnostics. How is Blue Earth Diagnostics positioning itself at the forefront of innovation in prostate cancer imaging? Michael: Prostate cancer has been at the center of our work from the beginning because healthcare professionals need accurate, actionable information to make important decisions for their patients. Molecular imaging has transformed our ability to see… The post Michael Wysocki on Precision Molecular Imaging & PSMA PET Innovation: Blue Earth Diagnostics’ Vision for Personalized Prostate Cancer Care appeared first on PharmaShots.
Read Full Article
Pharma Tech
Podcast: Patient advocates join the blood cancer ASCT vs CAR-T debate
Patient advocates in remission from MCL and FL discuss their treatment experiences with ASCT and CAR-T, while sharing views on latter's place in the treatment paradigm.
Read Full Article
Pharma Tech
“Hub-and-spoke” drug manufacturing set to benefit from new FDA rule
The proposed rule would allow multiple manufacturing units at different locations to register as one establishment.
Read Full Article
Pharma Tech
Takeda and Indonesia partner on plasma-derived therapies
Takeda and the Indonesian Government have announced a multi-phased collaboration to strengthen the country’s plasma ecosystem and expand access to PDMPs.
Read Full Article
Sponsored content
Featured promotional
News
Latest stories
Pharma Tech
Jul 13, 2026, 3:11 PM
Germany approves healthcare costs overhaul despite significant pharma opposition
There are a range of cost-containment measures across the bill that will create a significant healthcare system shakeup.
PharmaShots
Jul 13, 2026, 1:30 PM
Michael Wysocki on Precision Molecular Imaging & PSMA PET Innovation: Blue Earth Diagnostics’ Vision for Personalized Prostate Cancer Care
Shots: Saurabh: Molecular imaging is rapidly transforming oncology diagnostics. How is Blue Earth Diagnostics positioning itself at the forefront of innovation in prostate cancer imaging? Michael: Prostate cancer has been at the center of our work from the beginning because healthcare professionals need accurate, actionable information to make important decisions for their patients. Molecular imaging has transformed our ability to see… The post Michael Wysocki on Precision Molecular Imaging & PSMA PET Innovation: Blue Earth Diagnostics’ Vision for Personalized Prostate Cancer Care appeared first on PharmaShots.
Pharma Tech
Jul 13, 2026, 12:55 PM
Podcast: Patient advocates join the blood cancer ASCT vs CAR-T debate
Patient advocates in remission from MCL and FL discuss their treatment experiences with ASCT and CAR-T, while sharing views on latter's place in the treatment paradigm.
PharmaShots
Jul 13, 2026, 12:30 PM
BMS Reports US FDA’s NDA Acceptance of Mezigdomide Combination to Treat R/R Multiple Myeloma
Shots: Ref: Businesswire  |  Image: BMS  | Press Release Related News: BMS Partners with Hengrui Pharma in a Potential ~$15.2B Deal to Advance 13 Early-Stage Programs Across Oncology, Hematology, and Immunology PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post BMS Reports US FDA’s NDA Acceptance of Mezigdomide Combination to Treat R/R Multiple Myeloma appeared first on PharmaShots.
PharmaShots
Jul 13, 2026, 11:30 AM
GSK Reports P-II (AZUR-1) Trial Data on Jemperli for dMMR/MSI-H Locally Advanced Rectal Cancer
Shots: Ref: GSK  |  Image: GSK  | Press Release Related News: GSK & Spero Therapeutics Report the US FDA Approval of Utebzi for Complicated Urinary Tract Infections (cUTIs) PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post GSK Reports P-II (AZUR-1) Trial Data on Jemperli for dMMR/MSI-H Locally Advanced Rectal Cancer appeared first on PharmaShots.
Pharma Tech
Jul 13, 2026, 10:46 AM
“Hub-and-spoke” drug manufacturing set to benefit from new FDA rule
The proposed rule would allow multiple manufacturing units at different locations to register as one establishment.
News
Latest industry coverage
Google News
Jul 13, 2026, 9:01 PM
AIDS activists slam Biden R&D deal with Gilead over HIV prevention drug patents - STAT
AIDS activists slam Biden R&D deal with Gilead over HIV prevention drug patents  STAT
Google News
Jul 13, 2026, 9:00 PM
Korea FTC closes complaint as Daewoong pushes hub wholesaler reform - CHOSUNBIZ - Chosunbiz
Korea FTC closes complaint as Daewoong pushes hub wholesaler reform - CHOSUNBIZÂ Â Chosunbiz
Google News
Jul 13, 2026, 8:48 PM
Big Pharma's $300 Billion Patent Problem Fuels Biotech Deals - ETF Database
Big Pharma's $300 Billion Patent Problem Fuels Biotech Deals  ETF Database
Google News
Jul 13, 2026, 8:27 PM
[S-1/A] CTT PHARMACEUTICAL HOLDINGS, INC. Amends IPO Registration Statement - Stock Titan
[S-1/A] CTT PHARMACEUTICAL HOLDINGS, INC. Amends IPO Registration Statement  Stock Titan
Google News
Jul 13, 2026, 8:26 PM
Tarsus Pharmaceuticals Announces Executive Leadership Transition as Company Advances Next Phase of Growth - The Manila Times
Tarsus Pharmaceuticals Announces Executive Leadership Transition as Company Advances Next Phase of Growth  The Manila Times
Google News
Jul 13, 2026, 8:01 PM
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Â Â Business Wire
Google News
Jul 13, 2026, 7:49 PM
Stocks to Watch Today: HCL Tech, Biocon, Timken India, EMS, Alembic Pharma, PDS, ICICI Prudential AMC,... - Moneycontrol.com
Stocks to Watch Today: HCL Tech, Biocon, Timken India, EMS, Alembic Pharma, PDS, ICICI Prudential AMC,...  Moneycontrol.com
Google News
Jul 13, 2026, 7:34 PM
Korea targets generics, innovation in drug pricing overhaul - BioWorld News
Korea targets generics, innovation in drug pricing overhaul  BioWorld News
Google News
Jul 13, 2026, 7:33 PM
How Stronger Data Protection Reshaping India's Generic Drug Industry - BW Businessworld
How Stronger Data Protection Reshaping India's Generic Drug Industry  BW Businessworld
Sponsored placement
Featured promotions
Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer